State RI
Clinical Trials in Rhode Island
Recruiting clinical trials with at least one study location in Rhode Island. Data updated daily from ClinicalTrials.gov.
Top Conditions in Rhode Island
Opioid Use Disorder (2)Obesity (2)Anatomic Stage II Breast Cancer AJCC v8 (2)Breast Cancer (2)Leukemia (2)RISS Stage I Plasma Cell Myeloma (2)RISS Stage II Plasma Cell Myeloma (2)Acute Myeloid Leukemia (2)Metastatic Castration-resistant Prostate Cancer (2)Atrial Fibrillation (2)COVID-19 (2)Vision Loss Night (1)
Frequently Asked Questions — Clinical Trials in Rhode Island
How many clinical trials are currently recruiting in Rhode Island?
ClinicalMetric currently tracks 73 actively recruiting clinical trials with at least one location in Rhode Island. The total number of registered studies—including active but not currently enrolling trials—is 73. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Rhode Island?
Rhode Island hosts clinical trials across a broad range of medical conditions, including Opioid Use Disorder, Obesity, Anatomic Stage II Breast Cancer AJCC v8, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Rhode Island serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Rhode Island?
To join a clinical trial in Rhode Island, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Rhode Island maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Rhode Island
NCT07140783 Phase 3
Recruiting
OPI-NXYDLD-303 Safety and Efficacy of Phentolamine Ophthalmic Solution in Kerato...
Condition
Vision Loss Night
Enrollment
200 pts
Location
United States
Sponsor
Ocuphire Pharma, Inc.
NCT07420283 Phase 2
Recruiting
A Study of Brenipatide in Participants With Opioid Use Disorder
Condition
Opioid Use Disorder
Enrollment
465 pts
Location
United States, Canada, Puerto Rico
Sponsor
Eli Lilly and Company
NCT05458037 N/A
Recruiting
RCT of Pain Perception With Fast and Slow Tenaculum Application
Condition
Pain, Acute
Enrollment
150 pts
Location
United States
Sponsor
Women and Infants Hospital of
NCT06872307 N/A
Recruiting
Intervention to Enhance PrEP Persistence
Condition
HIV Prevention
Enrollment
300 pts
Location
United States
Sponsor
Brown University
NCT07500506 Phase 3
Recruiting
A Study to Learn About the Safety, Tolerability, and Immunogenicity of a Fifth D...
Condition
Lyme Disease
Enrollment
1,712 pts
Location
United States, Canada
Sponsor
Pfizer
NCT07115940 N/A
Recruiting
Medical Management With Endovascular Thrombectomy Versus Medical Management Alon...
Condition
Acute Ischemic Stroke
Enrollment
408 pts
Location
United States
Sponsor
Amrou Sarraj
NCT04181060 Phase 3
Recruiting
Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With E...
Condition
Advanced Lung Non-Squamous Non-Small Cell Carcinoma
Enrollment
300 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT04678154 Phase 3
Recruiting
Evaluation of a New Strategy for Protocolized Antibiotic Care for Severe Open Fr...
Condition
Post Operative Surgical Site Infection
Enrollment
1,200 pts
Location
United States
Sponsor
Major Extremity Trauma Researc
NCT06963827 Phase 3
Recruiting
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Condition
Kidney Disease
Enrollment
347 pts
Location
United States, Argentina, Australia
Sponsor
Takeda
NCT06944522 Phase 3
Recruiting
A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults Who Ha...
Condition
Parkinsons Disease (PD)
Enrollment
102 pts
Location
United States, Australia, Canada
Sponsor
BlueRock Therapeutics
NCT05647122 Phase 1
Recruiting
First in Human Study of AZD9592 in Solid Tumors
Condition
Advanced Solid Tumours
Enrollment
403 pts
Location
United States, Australia, Canada
Sponsor
AstraZeneca
NCT04239573 N/A
Recruiting
Comparing Two Methods to Follow Patients With Pancreatic Cysts
Condition
Pancreatic Carcinoma
Enrollment
4,606 pts
Location
United States, Canada, Puerto Rico
Sponsor
ECOG-ACRIN Cancer Research Gro
NCT05264779 N/A
Recruiting
The Periviable GOALS Decision Support Tool
Condition
Pregnancy Preterm
Enrollment
300 pts
Location
United States
Sponsor
Indiana University
NCT07545759 Phase 2
Recruiting
A Study of Brenipatide (LY3537031) in Participants With Irritable Bowel Syndrome...
Condition
Irritable Bowel Syndrome
Enrollment
531 pts
Location
United States, Belgium, Canada
Sponsor
Eli Lilly and Company
NCT06316830 Phase 2, Phase 3
Recruiting
Identifying Optimal Buprenorphine Dosing for Opioid Use Disorder Treatment and P...
Condition
Opioid Use Disorder
Enrollment
250 pts
Location
United States
Sponsor
Rhode Island Hospital
NCT06439953 N/A
Recruiting
Irrisept Solution for Instrumented Spine Surgery
Condition
Post-Op Complication
Enrollment
200 pts
Location
United States
Sponsor
Rhode Island Hospital
NCT06848335 N/A
Recruiting
Improving Physical Activity Participation in Latinas With Mindfulness
Condition
Inactivity
Enrollment
258 pts
Location
United States
Sponsor
Bess Marcus
NCT05317858 Phase 3
Recruiting
Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standar...
Condition
Brain Tumor
Enrollment
30 pts
Location
United States, Canada, South Korea
Sponsor
InSightec
NCT07000357 Phase 3
Recruiting
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a Histo...
Condition
Cardiovascular Disease
Enrollment
15,100 pts
Location
United States, Argentina, Brazil
Sponsor
AstraZeneca
NCT06166225 N/A
Recruiting
Strategies for Improving Remote-based Weight Loss (PATH Trial)
Condition
Obesity
Enrollment
210 pts
Location
United States
Sponsor
The Miriam Hospital
NCT06058377 Phase 3
Recruiting
Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy T...
Condition
Anatomic Stage II Breast Cancer AJCC v8
Enrollment
3,680 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT03488693 Phase 3
Recruiting
Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer
Condition
Breast Cancer
Enrollment
2,140 pts
Location
United States, Canada
Sponsor
Canadian Cancer Trials Group
NCT07228130 N/A
Recruiting
Microrandomized Trial to Optimize Use of Burden-reducing Self-monitoring Approac...
Condition
Obesity & Overweight
Enrollment
275 pts
Location
United States
Sponsor
The Miriam Hospital
NCT04968834 N/A
Recruiting
Protocol For Genomically Profiling, Collecting, Archiving And Distributing Blood...
Condition
Leukemia
Enrollment
300 pts
Location
United States
Sponsor
Dana-Farber Cancer Institute
NCT06564038 Phase 1, Phase 2
Recruiting
A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents f...
Condition
Chronic Lymphocytic Leukaemia
Enrollment
408 pts
Location
United States, Australia, China
Sponsor
AstraZeneca
Page 1 of 3 — 73 trials total
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology